Skip to main content
Public beta This website is in public beta – please give your feedback.

Example clinical scenario

A couple attend their anomaly scan at 19 weeks of pregnancy and are told that there is excessive fluid on both sides of their baby’s brain. The baby is diagnosed with moderate ventriculomegaly with a measurement of 14 millimetres. The pregnancy has otherwise been low risk and no associated anomalies can be seen.

When to consider genomic testing

  • Testing is usually offered in all cases of ventriculomegaly with or without other associated anomalies.
  • The chance of identifying an underlying genetic condition increases with more severe ventriculomegaly and where there are associated anomalies.
  • It is important that other causes, such as infection, are excluded.

What do you need to do?

  • Refer to local guidance regarding fetal medicine referral. Further review in a fetal medicine unit is usually warranted. A vaginal scan may be undertaken to provide better views of the brain. MRI assessment will be considered.
  • Initial genetic referral is not routinely indicated for isolated ventriculomegaly. A fetal medicine review will determine whether genomic testing is appropriate, and referral to clinical genetics will be considered if there are complex issues or multiple anomalies for which a genetic diagnosis is suspected.
  • The relevant team will review the NHS England National Genomic Test Directory eligibility criteria to determine which tests are available to your patient. The directory itself provides a list of all available tests.
  • Depending on the clinical scenario, a range of different genomic tests may be considered:
  • For all these tests, an amniocentesis or chorionic villus sample or fetal blood sample (in an EDTA tube) is required. For many of the tests (particularly whole genome and exome sequencing), parental samples are also needed or are helpful. Please refer to your local Genomic Laboratory Hub for details of test request forms and where to send samples.
  • Information about patient eligibility and test indications was correct at the time of writing. When requesting a test, please refer to the National Genomic Test Directory to confirm the right test for your patient.

Resources

For clinicians

For patients

↑ Back to top
  • Last reviewed: 06/03/2023
  • Next review due: 06/03/2024
  • Authors: Dr Jessica Woods
  • Reviewers: Donna Kirwan